W
WAVEMAN · COMPANY
FOCL · Edap Tms Sa
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

FOCL

EDAP TMS SA
MEDICAL DEVICES · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · CIK 0001041934
CLUSTER · 4 INSIDERSC-SUITE BUYING · 2☆ WATCH
INSIDER NET · 180D
$408.5K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
4
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
15
13F, latest reported quarter
REVENUE GROWTH
+1.6%
XBRL, annual
NET MARGIN
-41.5%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net +$408.5K over 180 days
+$408.5K over 90 days
more than 88% of Medical Devices
CONGRESS
no member of Congress has reported trading it
FUNDS
15 funds added or opened last quarter
below 79% of Medical Devices
REVENUE
+1.6% year over year
below 69% of Medical Devices
MARGIN
-41.5% net margin
below 70% of Medical Devices
BUYBACKS
no share repurchases reported
SHORT
0.7% of shares outstanding short · 4.3 days to cover · settled 2026-07-31
below 78% of Medical Devices
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
4 insiders independently bought a net $408.5K — no planned sales are queued against it.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +50.4%
+50.4%12M
-34%+20%+75%+130%2025-092025-102025-122026-032026-052026-072026-09 2026-08-14 · WILLSEY LANCE bought $237.5K2026-08-14 · Rhodes Ryan bought $99.8K2026-08-14 · Schulz Fran bought $47.5K2026-08-14 · Shah Sanket bought $23.8K
INSIDER BUY
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
4 insiders reported buying shares.
The record shows a net $408.5K bought by insiders over 180 days, 15 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, EDAP TMS SA insiders bought a net $408.5K of stock across 4 Form 4 purchases and sales, with 4 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
WILLSEY LANCE
Director
BUY
2026-08-14
50,000.0
$237.5K
Rhodes Ryan
Chief Executive Officer
BUY
2026-08-14
21,000.0
$99.8K
Shah Sanket
General Counsel & Corp Sec
BUY
2026-08-14
5,000.0
$23.8K
Schulz Fran
Director
BUY
2026-08-14
10,000.0
$47.5K
4 TRANSACTIONS ON RECORD · THIN RECORD, READ IT AS SUCH

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Soleus Capital Management, L.P.
7,309,254.0 sh
$37.9M
MORGAN STANLEY
3,336,872.0 sh
$17.3M
Rock Springs Capital Management LP
1,386,000.0 sh
$7.2M
FLAX POND CAPITAL, LLC
1,525,676.0 sh
$6.8M
Bruce & Co., Inc.
438,652.0 sh
$2.3M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
BRUCE FUND
$1.5M POSITION · AS OF 2026-03-31
0.4%
Fidelity Nasdaq Composite Index Fund
$99.5K POSITION · AS OF 2026-02-28
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Executive pay vs shareholder return
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2025
$1.7M
$2.7M
$860.5K
-38%
2024
$1.3M
$768.6K
$738.1K
-58%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$70.5M$69.4M$60.4M$55.1M
GROSS PROFIT$30.0M$28.7M$24.4M$24.2M
OPERATING INCOME$-24.7M$-22.2M$-19.8M$-4.3M
NET INCOME$-29.2M$-20.6M$-21.2M$-2.9M
EPS (DILUTED)-0.78-0.55-0.57-0.09
OPERATING CASH FLOW$-16.4M$-14.7M$-14.7M$-3.0M
CASH$20.5M$31.0M$43.5M$63.1M
LONG-TERM DEBT$15.9M$2.2M$2.0M$3.6M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →